FierceBiotech

U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T

AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men To view the multimedia ...
FierceBiotech

Endo Pharmaceuticals Provides Regulatory Update on AVEED(TM) (Testosterone Undecanoate) Injection

CHADDS FORD, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it received a complete response letter from the U.S. Food ...
MedPage Today

Hypogonadal Men See Better Heart Health on Testosterone Tx

BOSTON -- Men with hypogonadism on long-term testosterone therapy had improved cardiovascular health, according to researchers here. According to the 10-year outcomes of hypogonadal men, fewer men ...
ascopubs.org

Incidence and severity of prostate cancer in 360 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 8 years and 296 untreated hypogonadal controls.

Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence. This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers Symposium. This ...
Healio

New testosterone therapies offer options for men with hypogonadism

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Three new testosterone therapies offer innovative drug delivery options for men with hypogonadism ...
MedPage Today

Good, and Safe, Results Tied to Oral Testosterone in Men With Deficiency

MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...
Healio

Testosterone not linked to lasting benefit for older men without pathological hypogonadism

Please provide your email address to receive an email when new articles are posted on . The proportion of men who reported benefits 5 years after the T4DM trial was similar in the testosterone and ...
Medical Xpress

11 years of data add to the evidence for using testosterone therapy to treat obesity

New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), ...
EurekAlert!

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...
Nasdaq

Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio

- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years- JATENZO is an oral softgel testosterone undecanoate for testosterone ...
ascopubs.org

Incidence and severity of prostate cancer in 375 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 10 years and 296 untreated hypogonadal controls.

Association of polymorphism in YB-1 regulating androgen receptor V7 expression with efficacy of androgen-deprivation therapy in metastatic prostate cancer. This is an ASCO Meeting Abstract from the ...